January 22, 2020 by Chain Drug Review
A.T. Kearney, Kearney
Business, Leading Headlines, Retail News, Supplier News

CHICAGO — Kearney, the global consulting partnership formerly known as A.T. Kearney, announced earlier this month an all-encompassing rebrand. As part of a comprehensive review of Kearney’s existing brand and value proposition, the firm reached out to clients, firm partners, colleagues, and alumni for their perspectives on what they find distinctive and valuable in Kearney people,
November 20, 2019 by Chain Drug Review
A.T. Kearney, first annual 2019 Selfcare Benchmarking Study, Global Market Development Center | Retail Tomorrow (GMDC), Jason Maehara, Patrick Spear
Business, Leading Headlines, Pharmacy

COLORADO SPRINGS, Colo. — Leading retail industry trade association Global Market Development Center (GMDC)|Retail Tomorrow, in partnership with global strategy and management consulting firm A.T. Kearney, has released the results of its first annual 2019 Selfcare Benchmarking Study. The study provides emerging industry insights into how self care — the mindset and lifestyle that inspire consumers to embrace proactive life
October 31, 2019 by Chain Drug Review
A.T. Kearney, A.T. Kearney's 2019 Global Retail Development Index (GRDI)
Business, Leading Headlines, Retail News

CHICAGO — Global retailing remains a paradox. Even as social media and ecommerce fuel the evolution of a truly global consumer, retailing in emerging economics continues to be affected by local realities such as Internet connectivity, availability and cost of labor, and government factors ranging from taxation policy and trade wars to armed conflict. These
September 17, 2019 by Chain Drug Review
A.T. Kearney, Gen Z, greg portell, How Gen Z's Concern With Emotional Health Fuels Retail Growth And Failure
Business, Leading Headlines

CHICAGO — Gen Z is more concerned with its mental and physical health than Millennials or Gen X, self-reporting higher stress responses to both the news and social media. And, this heightened anxiety is influencing how they shop, benefiting traditional brick & mortar retailers. Those are some of the conclusions in A.T. Kearney’s new report,
July 11, 2019 by Chain Drug Review
A.T. Kearney, emerging retail technologies, Suketu Gandhi
Business, Retail News, Technology

CHICAGO — When faced with the existing show-and-tell of emerging retail technologies, U.S. consumers report that they’ve heard the “tell” but have yet to see the “show.” Global management consulting firm, A.T. Kearney has released a study which looks into consumer knowledge and experience of various emerging in-store technologies. Notes Suketu Gandhi, partner in the
March 19, 2019 by Chain Drug Review
A.T. Kearney, cannabidiol (CBD), Charlotte's Web, Pharmaca, Sagely Naturals, Select CBD
March 18, 2019

“The readiness is all.” It’s hard to think of an emerging product category where retailers and suppliers have taken Hamlet’s admonition more seriously than CBD. As attitudes about cannabis, hemp and products derived from them have shifted, and the legal and regulatory restrictions around them have started to unravel, many chains and an extensive roster
January 22, 2019 by Randy Burt and Todd Huseby
A.T. Kearney, cannabidiol (CBD), legal cannabis-based products, Randy Burt, Todd Huseby
Business, January 21, 2019, Leading Headlines, Opinion, Retail News

Editor’s note: This is Part I of an article that ran in the 1/21/19 issue of CDR. As legal cannabis-based products continue to find their way to market, promising to redefine entire categories from health, beauty and wellness to food and beverage in their wake, most chain drug retailers are scrambling to calculate the impact
January 17, 2019 by Chain Drug Review
A.T. Kearney, Cervello
Supplier News

CHICAGO — A.T. Kearney has acquired Cervello, an elite business analytics and data management consultancy. Operating as Cervello, an A.T. Kearney company, its team of data engineers, data scientists, and developers will work closely with Kearney client service teams worldwide to power client performance improvement and transformation programs with technology consulting, analytics, and data-driven insights.
November 21, 2018 by Chain Drug Review
2018 Holiday Shopping, A.T. Kearney, A.T. Kearney's 2018 Holiday Shopping Survey: How Retailers Can Capitalize on Last Year's Lessons
Business, Leading Headlines, Retail News

CHIGACO — Holiday shoppers are more than prepared to buy in force this year. The only question is who will capture their dollars. Three out of four consumers (76%) plan to spend as much or more than they did last year, but, according to A.T. Kearney’s 2018 Holiday Shopping Survey: How Retailers Can Capitalize on
November 5, 2018 by Jerry Cacciotti
A.T. Kearney, health care, Jerry Cacciotti, technology
Issue 11-05-2018, Opinion

Editor’s note: The second in a series of seven articles by A.T. Kearney on the trends that are radically transforming the health sector. There is no question that science is rapidly accelerating the health care opportunities we see in the marketplace. Broader genetics capabilities could mean new services and treatments based on genetic makeup that
October 23, 2018 by Chain Drug Review
A.T. Kearney, American and Canadian consumer attitudes toward legalized cannabis, cannabis study, Randy Burt
Business, Leading Headlines

CHICAGO — Recent research by A.T. Kearney into American and Canadian consumer attitudes toward legalized cannabis revealed that more than three-quarters (76%) would try medicinal cannabis products and about half would try cannabis-enhanced consumer products such as snack foods (55%), nutritional supplements (50%) and cosmetics (43%). While North American attitudes toward marijuana are relaxing almost as
September 6, 2018 by Michael Zimmerman and Todd Huseby
A.T. Kearney, A.T. Kearney’s “2018 State of Logistics Report”, Michael Zimmerman, Todd Huseby
Issue 08-27-2018, Opinion

The high value of pharmaceutical shipments has traditionally meant that all parties in the chain drug industry were primarily concerned with quality. They needed a reliable, transparent solution. Given that shipping represented a tiny percentage of drug costs, price was a lesser concern. But recently shipping rates have increased sharply. Is there anything the industry
May 4, 2018 by Greg Portell
A.T. Kearney, greg portell, neumarket
Issue 04-23-2018, Opinion

While 2018 looks to be on pace to continue the recent fervid spate of traditional mergers and acquisitions — measured in terms of number of deals, size of deals, or both — it may be best remembered as the year that a bold new approach to M&As that we call “neumarkets” revolutionized retailing and a
March 19, 2018 by Hemal Nagarsheth and Chain Drug Review
A.T. Kearney, Amazon Go, chain drug store retailers, digital payments, drug store retailers, frictionless checkout, frictionless payment methods, Hemal Nagarsheth, payments data, Walmart Pay
2018, Issue 03-19-2018, Issues, Opinion

We are now more than 20 years into the e-commerce era of retail. As many brick-and-mortar retail sectors have found creative ways to combat the online threat, pharmacy chains too are identifying the most effective solutions. One area that offers an opportunity for improvement is payments. For digitally savvy customers, the checkout experience — the